APS seeking cooperation opportunities with worldwide biomedical research institutions, companies and professional scientists during all stages of the drug development including the discovery stage, clinical stage and global commercialization stage through flexible co-development, license-out and license-in cooperation models. APS is Looking forward to exploring frontier technology and innovating cancer breakthrough therapies, and improving the human health with partners all over the world.
We are willing to cooperate with worldwide biomedical research institutions, companies and academic institutions in multi-directional strategic cooperation, based on our team's leadership and research and development capabilities, with complementary resources, win-win cooperation, to create the international frontier core skeleton oncology pipeline.
We are willing to license-out our independently developed and patented pipelinesby global or regional rights.
We are willing tolicense-in first-in-class or highly differentiated drug candidates from global partners for development and commercialization in the global market.
We are willing to cooperate with the cutting-edge biotechnology professionals to jointly create breakthrough targeted oncology pipelines, and enjoy the benefits for life with a high equity incentive, so as to realize their personal value in cancer therapy field.